Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

NCT02834286 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Rituximab
DRUG: Eltrombopag
DRUG: Dexamethasone

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez